Ayala Pharmaceuticals Inc (ADXS)
0.555
0.00 (0.00%)
USD |
OTCM |
Apr 26, 15:38
Ayala Pharmaceuticals Enterprise Value: 26.69M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 26.69M |
| April 24, 2024 | 26.26M |
| April 23, 2024 | 26.26M |
| April 22, 2024 | 27.62M |
| April 19, 2024 | 27.62M |
| April 18, 2024 | 27.54M |
| April 17, 2024 | 30.75M |
| April 16, 2024 | 28.86M |
| April 15, 2024 | 29.71M |
| April 12, 2024 | 31.71M |
| April 11, 2024 | 31.71M |
| April 10, 2024 | 29.24M |
| April 09, 2024 | 29.24M |
| April 08, 2024 | 31.71M |
| April 05, 2024 | 29.14M |
| April 04, 2024 | 29.14M |
| April 03, 2024 | 29.99M |
| April 02, 2024 | 30.54M |
| April 01, 2024 | 30.54M |
| March 28, 2024 | 30.54M |
| March 27, 2024 | 33.10M |
| March 26, 2024 | 33.53M |
| March 25, 2024 | 30.12M |
| March 22, 2024 | 28.84M |
| March 21, 2024 | 28.41M |
| Date | Value |
|---|---|
| March 20, 2024 | 28.84M |
| March 19, 2024 | 29.78M |
| March 18, 2024 | 28.73M |
| March 15, 2024 | 29.69M |
| March 14, 2024 | 31.82M |
| March 13, 2024 | 33.10M |
| March 12, 2024 | 34.81M |
| March 11, 2024 | 33.96M |
| March 08, 2024 | 36.18M |
| March 07, 2024 | 36.94M |
| March 06, 2024 | 35.23M |
| March 05, 2024 | 35.86M |
| March 04, 2024 | 39.09M |
| March 01, 2024 | 42.10M |
| February 29, 2024 | 39.97M |
| February 28, 2024 | 39.97M |
| February 27, 2024 | 39.97M |
| February 26, 2024 | 41.61M |
| February 23, 2024 | 41.20M |
| February 22, 2024 | 39.58M |
| February 21, 2024 | 44.61M |
| February 20, 2024 | 36.85M |
| February 16, 2024 | 34.33M |
| February 15, 2024 | 28.88M |
| February 14, 2024 | 32.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.208M
Minimum
Sep 28 2023
1.394B
Maximum
Feb 17 2021
227.06M
Average
65.35M
Median
Apr 27 2022
Enterprise Value Benchmarks
| Taro Pharmaceutical Industries Ltd | 694.38M |
| InspireMD Inc | 5.896M |
| BiomX Inc | 14.83M |
| Alpha Tau Medical Ltd | 91.03M |
| Pluri Inc | 21.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.67M |
| Total Expenses (Quarterly) | 8.78M |
| EPS Diluted (Quarterly) | -2.081 |
| Earnings Yield | -1.58K% |
| Normalized Earnings Yield | -2068.47 |